Private Harbour Investment Management & Counsel LLC Has $2.33 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Private Harbour Investment Management & Counsel LLC decreased its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 5.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,295 shares of the company’s stock after selling 886 shares during the quarter. Zoetis comprises approximately 2.6% of Private Harbour Investment Management & Counsel LLC’s investment portfolio, making the stock its 14th biggest holding. Private Harbour Investment Management & Counsel LLC’s holdings in Zoetis were worth $2,329,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of ZTS. Howard Capital Management Group LLC grew its holdings in shares of Zoetis by 0.8% in the 3rd quarter. Howard Capital Management Group LLC now owns 104,866 shares of the company’s stock valued at $20,489,000 after buying an additional 883 shares during the period. Principal Financial Group Inc. grew its stake in Zoetis by 17.3% in the third quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company’s stock valued at $464,497,000 after acquiring an additional 351,372 shares during the period. Kingsview Wealth Management LLC increased its holdings in shares of Zoetis by 8.5% in the third quarter. Kingsview Wealth Management LLC now owns 9,889 shares of the company’s stock worth $1,932,000 after acquiring an additional 775 shares in the last quarter. Larson Financial Group LLC raised its position in shares of Zoetis by 14.8% during the third quarter. Larson Financial Group LLC now owns 1,588 shares of the company’s stock worth $310,000 after purchasing an additional 205 shares during the period. Finally, Harvest Fund Management Co. Ltd lifted its holdings in shares of Zoetis by 237.3% during the 3rd quarter. Harvest Fund Management Co. Ltd now owns 2,159 shares of the company’s stock valued at $422,000 after purchasing an additional 1,519 shares in the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on ZTS shares. StockNews.com upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Stifel Nicolaus dropped their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Barclays lifted their price target on Zoetis from $242.00 to $244.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, Piper Sandler upped their price objective on Zoetis from $200.00 to $205.00 and gave the stock an “overweight” rating in a research report on Thursday, February 27th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Zoetis has an average rating of “Buy” and a consensus price target of $215.90.

Insider Buying and Selling

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $170.00, for a total value of $55,420.00. Following the completion of the sale, the executive vice president now owns 15,781 shares in the company, valued at $2,682,770. The trade was a 2.02 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Willie M. Reed sold 1,210 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total transaction of $201,029.40. Following the transaction, the director now owns 11,245 shares in the company, valued at approximately $1,868,244.30. The trade was a 9.71 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,862 shares of company stock valued at $312,254. Insiders own 0.16% of the company’s stock.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $161.29 on Wednesday. The company has a current ratio of 1.75, a quick ratio of 1.08 and a debt-to-equity ratio of 1.09. The company has a market capitalization of $72.22 billion, a P/E ratio of 29.49, a P/E/G ratio of 2.78 and a beta of 0.94. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.33. The stock has a 50 day moving average of $166.64 and a 200-day moving average of $175.02.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.03. The company had revenue of $2.32 billion for the quarter, compared to analyst estimates of $2.30 billion. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. As a group, equities research analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.24%. Zoetis’s dividend payout ratio (DPR) is currently 36.56%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.